Anti PD-1 Neo-adjuvant Treatment for NSCLC

Clinical trial NCT02938624 · COMPLETED

Trial details

NCT number: NCT02938624
Sponsor: Jair Bar, M.D., Ph.D.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Carcinoma Stage I Stage II

Start date: 2017-01-07
Primary completion: 2021-08-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.